Tenon Medical Posts 24% Q1 Revenue Growth to $37.8 M, Eyes European Expansion
Tenon Medical reported record Q1 2026 revenue of $37.8 million, up 24% year-over-year, driven by strong demand for its surgical instrumentation portfolio. Management disclosed plans to expand European distribution channels and increase R&D spending by 15% to accelerate minimally invasive device launches.
1. Record Quarterly Revenue
Tenon Medical achieved its highest quarterly sales in Q1 2026 with $37.8 million in revenue, representing a 24% increase versus Q1 2025. Growth was fueled by robust adoption of its orthopedic and spinal surgical instrument lines across North American hospitals.
2. Strategic Expansion Plans
Leadership outlined intentions to broaden distribution in key European markets, supported by new regional partnerships. The company also committed to boosting R&D investment by 15%, funding accelerated development of next-generation minimally invasive surgical tools.